Business · 26/02/1996Updated: 10/18/2026 · 1 min read
FDA Releases Draft Document on Regulation of Placental/Umbilical Cord Blood Stem Cell Products
Summary
The FDA is releasing a draft document outlining its approach to regulating placental/umbilical cord blood stem cell products for transplantation, inviting public comments on the proposal.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →